grant | 2025 - 2026
Functional and Transcriptomic analysis of Antisense Oligomer Mediated Modulation of C9ORF72 variant expression
Perron Institute for Neurological and Translational Science
Grant no. 22763.
grant | 2024 - 2025
Initial studies of how well a potential new drug for treating motor neuron disease gets to where it needs to act in a living system and to learn how this distribution affects safety and effectiveness
Western Australian Department of Health
Grant no. 22395.
grant | 2023 - 2023
Modulation of the autophagy pathway to clear TDP-43 aggregation as a therapeutic strategy for ALS and FTLD
Perron Institute for Neurological and Translational Science
Grant no. 21369.
grant | 2022 - 2024
Modulation of the Autophagy Pathway to treat Neurogenerative Diseases
General
Grant no. 21102.
grant | 2021 - 2025
Antisense oligonucleotides targeted to the p62 PB1 domain as a potential therapy in ALS.
General
Grant no. 20203.
grant | 2021 - 2021
Mass Spectrometry Imaging of CPP-PMO Conjugates - A pilot study for Pyc Therapeutics Ltd.
General
Grant no. 20234.
grant | 2020 - 2021
Antisense oligonucleotide targeting of p62-mediated TDP-43 pathology as a treatment for amyotrophic lateral sclerosis
General
Grant no. 19825.
grant | 2020 - 2021
Improving drug delivery in inherited eye diseases
General
Grant no. 19831.
grant | 2020 - 2022
Modulation of accessory pathways to ameliorate neurodegenerative disease
General
Grant no. 19832.
grant | 2020 - 2021
Novel molecular plugs for accurate SARS-CoV-2 paper test from swabs in minutes and for treating COVID-19
General
Grant no. 19662.
grant | 2020 - 2023
Perron Institute & MU Contribution & Revenue Sharing Agreement
General
Grant no. 19116.
grant | 2020 - 2023
Perron Sponsored Position - Dr Sarah Rea
General
Grant no. 19158.
grant | 2020 - 2023
Pre-clinical development of a SOD1 genetic therapy in sporadic ALS: enabling investigational new drug submission
General
Grant no. 19597.
grant | 2020 - 2024
PYC Partner Salary Support for Research Assistant Alanis Lima
General
Grant no. 19751.
grant | 2020 - 2021
Risk genes in sporadic Inclusion Body Myositis (IBM)
General
Grant no. 19819.
grant | 2020 - 2024
UWA led - Accelerating the identification and treatment of splice-altering mutations underlying inherited retinal diseases
General
Grant no. 18956.
grant | 2020 - 2021
Validation of motor neuron disease patient olfactory neural stem cells as a drug evaluation platform
General
Grant no. 19968.
grant | 2020 - 2021
WA MND Research Consortium:
General
Grant no. 19668.
grant | 2019 - 2019
Blocking of autoantibodies using oligonucleotides in Inclusion Body Myositis.
General
Grant no. 18534.
grant | 2019 - 2019
Exon skipping strategy as a treatment for recessive Ullrich Congenital Muscular Dystrophy
The Orphan Disease Center
Grant no. 18607.
grant | 2019 - 2020
Hosting services: TESTOV Data Management
General
Grant no. 18718.
grant | 2018 - 2019
{Extension} BPA Super Science Investment Fund
General
Grant no. 18415.
grant | 2018 - 2019
Antisense mediated inhibition of PCSK9 activity: potential therapy for familial hypercholesterolemia
Perron Institute for Neurological and Translational Science (Australia, Nedlands) - WANRI
Grant no. 18588.
grant | 2018 - 2019
FH Registry - Hosting and maintenance agreement
General
Grant no. 18208.
grant | 2018 - 2019
Lions Eye Institute led - Stargardt macular degeneration: finding new genetic mutations
General
Grant no. 18496.
grant | 2018 - 2021
Perron Scholarship - Di Huang
General
Grant no. 18121.
grant | 2018 - 2019
QUT led - Accelerating precision therapies through digital infrastructure for adaptive trials and trial-ready cohort studies
General
Grant no. 17947.
grant | 2018 - 2021
Targeted alternative splicing: a common therapeutic platform to treat inherited diseases
General
Grant no. 17610.
grant | 2018 - 2018
Underpinning National Biological Datasets with National Biosciences Computational Infrastructure and Services
General
Grant no. 18242.
grant | 2018 - 2020
UWA led - DBHS Protein RNA interactions in health and disease
General
Grant no. 17671.
grant | 2017 - 2019
Mapping functional domains of the dystrophin protein based on exon structure
General
Grant no. 17132.
grant | 2017 - 2018
Mapping redundant exons through the generation of animal models of human disease
General
Grant no. 17993.
grant | 2017 - 2022
Perron Scholarship - Sarah Leishman
General
Grant no. 17977.
grant | 2016 - 2017
Ad-hoc consultancy
General
Grant no. 17321.
grant | 2016 - 2016
Antisense oligomer induced splice intervention targeting ITGA4 and LINGO1 as a combined treatment for multiple sclerosis.
Multiple Sclerosis Research Australia (Australia, North Sydney)
Grant no. 16641.
grant | 2016 - 2017
Ianthe Pitout - TEAM Spencer Muscular Dystrophy WA PhD Scholarship Program for 2016
General
Grant no. 17001.
grant | 2016 - 2019
Li Dunhui - Muscular Dystrophy WA - Harold & Sylvia Rowell PhD Scholarship for 2016
General
Grant no. 17002.
grant | 2016 - 2017
Targeted delivery of splice switching oligonucleotides to enhance treatment of Duchenne muscular dystrophy
General
Grant no. 16784.
grant | 2015 - 2015
Antisense oligonucleotides for the treatment of disorders of surfactant metabolism causing childhood interstitial lung disease.
General
Grant no. 16477.
grant | 2015 - 2019
Sarepta Master Agreement
General
Grant no. 16711.
grant | 2015 - 2017
Scoping new exon skipping applications.
Sarepta Therapeutics (United States, Cambridge)
Grant no. 17048.
grant | 2015 - 2016
Splice correction as a treatment for rare diseases
General
Grant no. 15734.
grant | 2014 - 2015
Developing a splice switching therapy to correct a common defect in GAA causing adult onset Glycogen storage disease II
General
Grant no. 15745.
grant | 2014 - 2016
UWA Lead - The L-type calcium channel as a reporter of successful morpholino oligomer therapy in treatment of Duchenne Muscular Dystrophy cardimyopathy
General
Grant no. 15846.
grant | 2013 - 2015
Antisense oligomer induced suppression of target genes implicated in Multiple Sclerosis
General
Grant no. 15464.
grant | 2013 - 2016
Oligomer Design & Validation for DMD: Quantum Improvements in Exon Skipping
General
Grant no. 15417.
grant | 2013 - 2015
Optimization of splice switching therapies to treat Duchenne muscular dystrophy
General
Grant no. 15063.